While Pharma companies, Biotechs, and CROs are expanding their use of mHealth technologies, they are not expanding the use of it evenly across all therapeutic areas. ISR tallied up responses from each of these company types, and found that the Cardiovascular area has seen the most overall uptake among them, with a third of respondents saying their company had used mHealth technologies in Cardiovascular studies.
Originally published in Life Science Leader.
View Resource